nach oben

Pituitary

Erschienen in:

01.06.2008

Central hypothyroidism

verfasst von: Andrea Lania, Luca Persani, Paolo Beck-Peccoz

Erschienen in: Pituitary | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

Central hypothyroidism (CH) is a rare cause of hypothyroidism due to an insufficient stimulation of an otherwise normal thyroid gland and it is caused by either pituitary (secondary hypothyroidism) or hypothalamic (tertiary hypothyroidism) defects. The diagnosis of CH is usually suggested by the finding of lowered thyroid hormone concentrations, associated with inappropriately low/normal TSH levels. Restoration and maintenance of euthyroidism represent the therapeutic goals in all forms of CH. On these basis, the vast majority of patients with CH is treated with standard levo-thyroxine (L-T4) therapy which is tailored according to FT4 circulating levels that should be maintained in the normal range.

Horimoto M, Nishikawa M, Ishihara T, Yoshikawa N, Yoshimura M, Inada M (1995) Bioactivity of thyrotropin (TSH) in patients with central hypothyroidism: comparison between in vivo 3, 5, 3 -triiodothyronine response to TSH and in vitro bioactivity of TSH. J Clin Endocrinol Metab 80:1124–1128. doi:10.1210/jc.80.4.1124 PubMedCrossRef

Persani L, Ferretti E, Borgato S, Faglia G, Beck-Peccoz P (2000) Circulating TSH bioactivity in sporadic central hypothyroidism. J Clin Endocrinol Metab 85:3631–3635. doi:10.1210/jc.85.10.3631 PubMedCrossRef

Beck-Peccoz P, Amr S, Menezes-Ferreira MM, Faglia G, Weintraub BD (1985) Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism. Effect of treatment with thyrotropin-releasing hormone. N Engl J Med 312:1085–1090PubMed

Beck-Peccoz P, Persani L (1994) Variable biological activity of thyroid-stimulating hormone. Eur J Endocrinol 131:331–340PubMed

Sherman SI, Gopal J, Haugen BR et al (1999) Central hypothyroidism associated with retinoid X receptor-selective ligands. N Engl J Med 340:1075–1079. doi:10.1056/NEJM199904083401404 PubMedCrossRef

Medeiros-Neto G, Herodotou DT, Rajan S et al (1996) A circulating, biologically inactive thyrotropin caused by a mutation in the beta subunit gene. J Clin Invest 97:1250–1256. doi:10.1172/JCI118540 PubMedCrossRef

Bonomi M, Proverbio MC, Weber G, Chiumello G, Beck-Peccoz P, Persani L (2001) Hyperplastic pituitary gland, high serum glycoprotein hormone α-subunit, and variable circulating thyrotropin (TSH) levels as hallmark of central hypothyroidism due to mutations of the TSHβ gene. J Clin Endocrinol Metab 86:1600–1604. doi:10.1210/jc.86.4.1600 PubMedCrossRef

Szkudlinski MW, Fremont V, Ronin C, Weintraub BD (2002) Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships. Physiol Rev 82:473–502PubMed

Collu R, Tang J, Castagne J et al (1997) A novel mechanism for isolated central hypothyroidism: inactivating mutations in the thyrotropin-releasing hormone receptor gene. J Clin Endocrinol Metab 82:1561–1565. doi:10.1210/jc.82.5.1561 PubMedCrossRef

10.

Dattani MT, Robison IC (2000) The molecular basis for developmental disorders of the pituitary gland. Clin Genet 57:337–346. doi:10.1034/j.1399-0004.2000.570503.x PubMedCrossRef

11.

Cohen LE, Radovick S (2002) Molecular basis of combined pituitary hormone deficiencies. Endocr Rev 23:431–442. doi:10.1210/er.2001-0030 PubMedCrossRef

12.

Clement K, Vaisse C, Lahlou N et al (1998) A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392:398–401. doi:10.1038/32911 PubMedCrossRef

13.

Nillni EA, Vaslet C, Harris M, Hollenberg A, Bjorbak C, Flier JS (2000) Leptin regulates prothyrotropin-releasing hormone biosynthesis. Evidence for direct and indirect pathways. J Biol Chem 275:36124–36133. doi:10.1074/jbc.M003549200 PubMedCrossRef

14.

Baloch Z, Carayon P, Conte-Devolx B et al (2003) Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13:3–126PubMedCrossRef

15.

van Tijn DA, de Vijlder JJ, Verbeeten B Jr, Verkerk PH, Vulsma T (2005) Neonatal detection of congenital hypothyroidism of central origin. J Clin Endocrinol Metab 90:3350–3359. doi:10.1210/jc.2004-2444 PubMedCrossRef

16.

Smallridge RC (1996) Metabolic, physiological, and clinical indexes of thyroid function. In: Braverman LE, Utiger RD (eds) The thyroid, 7th edn. Lippincott, Philadelphia, pp 397–405

17.

Ferretti E, Persani L, Jaffrain-Rea ML, Giambona S, Tamburrano G, Beck-Peccoz P (1999) Evaluation of the adequacy of l-T4 replacement therapy in patients with central hypothyroidism. J Clin Endocrinol Metab 84:924–929. doi:10.1210/jc.84.3.924 PubMedCrossRef

18.

Jorgensen JO, Moller J, Laursen T, Orskov H, Christiansen JS, Weeke J (1994) Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults. Clin Endocrinol 41:609–614. doi:10.1111/j.1365–2265.1994.tb01826.x CrossRef

19.

Jorgensen JO, Pedersen SA, Laurberg P, Weeke J, Skakkebaek NE, Christiansen JS (1989) Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism. J Clin Endocrinol Metab 69:1127–1132PubMed

20.

Alexopoulou O, Beguin C, De Nayer P, Maiter D (2004) Clinical and hormonal characteristics of central hypothyroidism at diagnosis and during follow-up in adult patients. Eur J Endocrinol 150:1–8. doi:10.1530/eje.0.1500001 PubMedCrossRef

21.

Andersen S, Pedersen KM, Bruun NH, Laurberg P (2002) Narrow individual variations in serum T4 and T3 in normal subjects: a clue to understanding of subclinical thyroid disease. J Clin Endocrinol Metab 87:1068–1072. doi:10.1210/jc.87.3.1068 PubMedCrossRef

22.

Rose SR, Lustig RH, Pitukcheewanont P et al (1999) Diagnosis of hidden central hypothyroidism in survivors of child cancer. J Clin Endocrinol Metab 84:4472–4479. doi:10.1210/jc.84.12.4472 PubMedCrossRef

23.

Yamakita N, Komaki T, Takao T, Murai T, Hashimoto K, Yasuda K (2001) Usefulness of thyrotropin (TSH)-releasing hormone test and nocturnal surge of TSH for diagnosis of isolated deficit of TSH secretion. J Clin Endocrinol Metab 86:1054–1060. doi:10.1210/jc.86.3.1054 PubMedCrossRef

24.

Costom BH, Grumbach MM, Kaplan SL (1971) Effect of thyrotropin-releasing factor on serum thyroid-stimulating hormone. An approach to distinguishing hypothalamic from pituitary forms of idiopathic hypopituitary dwarfism. J Clin Invest 50:2219–2225. doi:10.1172/JCI106717 PubMedCrossRef

25.

Faglia G, Beck-Peccoz P, Ferrari C et al (1973) Plasma thyrotropin response to thyrotropin-releasing hormone in patients with pituitary and hypothalamic disorders. J Clin Endocrinol Metab 37:595–601PubMed

26.

Mehta A, Hindmarsh PC, Stanhope RG, Brain CE, Preece MA, Dattani MT (2003) Is the thyrotropin-releasing hormone test necessary in the diagnosis of central hypothyroidism in children. J Clin Endocrinol Metab 88:5696–5703. doi:10.1210/jc.2003-030943 PubMedCrossRef

27.

Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr (1999) Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med 340:424–429. doi:10.1056/NEJM199902113400603 PubMedCrossRef

28.

Clyde PW, Harari AE, Getka EJ, Shakir KMM (2003) Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyrodism. A randomized controlled trial. JAMA 290:2952–2958. doi:10.1001/jama.290.22.2952 PubMedCrossRef

29.

Helfand M, Crapo LM (1990) Monitoring therapy in patients taking levothyroxine. Ann Intern Med 113:450–454PubMed

30.

Oppenheimer JH, Braverman LE, Toft A, Jackson IM, Ladenson PW (1995) A therapeutic controversy. Thyroid hormone treatment: when and what? J Clin Endocrinol Metab 80:2873–2883. doi:10.1210/jc.80.10.2873 PubMedCrossRef

31.

Carrozza V, Csako G, Yanovski JA et al (1999) Levothyroxine replacement therapy in central hypothyroidism: a practice report. Pharmacotherapy 19:349–355. doi:10.1592/phco.19.4.349.30940 PubMedCrossRef

32.

Shimon I, Cohen O, Lubetsky A, Olchovsky D (2002) Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidism. Thyroid 12:823–827. doi:10.1089/105072502760339406 PubMedCrossRef

33.

Beck-Peccoz P, Brucker-Davis F, Persani L, Smallridge RC, Weintraub BD (1996) Thyrotropin-secreting pituitary tumors. Endocr Rev 17:610–638. doi:10.1210/er.17.6.610 PubMedCrossRef

34.

Beck-Peccoz P, Persani L (2001) TSH-producing adenomas. In: DeGroot LJ, Jameson JL (eds) Endocrinology, 4th edn, Chapter 24. WB Saunders, Philadelphia, pp 321–328

35.

Griffin JE (1990) Hypothyroidism in the elderly. Am J Med Sci 299:334–345. doi:10.1097/00000441-199005000-00009 PubMedCrossRef

36.

Porretti S, Giavoli C, Ronchi C et al (2002) Recombinant human GH replacement therapy and thyroid function in a large group of adult GH-deficient patients: when does L-T4 therapy become mandatory? J Clin Endocrinol Metab 87:2042–2045. doi:10.1210/jc.87.5.2042 PubMedCrossRef

37.

Arafah BM (2001) Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med 344:1743–1749. doi:10.1056/NEJM200106073442302 PubMedCrossRef

38.

Ain KB, Mori Y, Refetoff S (1987) Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration. J Clin Endocrinol Metab 65:689–696PubMed

39.

Grunfeld C, Sherman BM, Cavalieri RR (1988) The acute effects of human growth hormone administration on thyroid function in normal men. J Clin Endocrinol Metab 67:1111–1114PubMedCrossRef

40.

Portes ES, Oliveira JH, Maccagnan P, Abucham J (2000) Changes in serum thyroid hormones levels and their mechanisms during long-term growth hormone (GH) replacement therapy in GH deficient children. Clin Endocrinol 53:183–189. doi:10.1046/j.1365-2265.2000.01071.x CrossRef

41.

Giavoli C, Porretti S, Ferrante E et al (2003) Recombinant hGH replacement therapy and the hypothalamus-pituitary-thyroid axis in children with GH deficiency: when should we be concerned about the occurrence of central hypothyroidism? Clin Endocrinol 59(806):810. doi:10.1046/j.1365–2265.2003.01892.x

42.

Koch CA, Sarlis NJ (2001) The spectrum of thyroid diseases in childhood and its evolution during transition to adulthood: natural history, diagnosis, differential diagnosis and management. J Endocrinol Invest 24:659–675PubMed

43.

Selva KA, Mandel SH, Rien L et al (2002) Initial treatment dose of L-thyroxine in congenital hypothyroidism. J Pediatr 141:786–792. doi:10.1067/mpd.2002.128887 PubMedCrossRef

Titel: Central hypothyroidism
verfasst von: Andrea Lania
Luca Persani
Paolo Beck-Peccoz
Publikationsdatum: 01.06.2008
Verlag: Springer US
Erschienen in: Pituitary / Ausgabe 2/2008
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI: https://doi.org/10.1007/s11102-008-0122-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Eingreifen von Umstehenden rettet vor Erstickungstod!

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2008

Dynamic testing in Cushing’s syndrome

Female hypogonadism: evaluation of the hypothalamic–pituitary–ovarian axis

Secondary hypoadrenalism

Systemic illness

Dynamic tests for the diagnosis and assessment of treatment efficacy in acromegaly